Walker Long

7.3k total citations · 3 hit papers
74 papers, 5.2k citations indexed

About

Walker Long is a scholar working on Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Surgery. According to data from OpenAlex, Walker Long has authored 74 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 30 papers in Endocrine and Autonomic Systems and 17 papers in Surgery. Recurrent topics in Walker Long's work include Neonatal Respiratory Health Research (42 papers), Neuroscience of respiration and sleep (30 papers) and Respiratory Support and Mechanisms (22 papers). Walker Long is often cited by papers focused on Neonatal Respiratory Health Research (42 papers), Neuroscience of respiration and sleep (30 papers) and Respiratory Support and Mechanisms (22 papers). Walker Long collaborates with scholars based in United States, Canada and China. Walker Long's co-authors include James W. Crow, Maria M. Jöbsis, Linda Clayton, Lewis J. Rubin, Stuart Rich, Robyn J. Barst, Bertron Μ. Groves, David B. Badesch, Srinivas Murali and David Langleben and has published in prestigious journals such as New England Journal of Medicine, Circulation and Gastroenterology.

In The Last Decade

Walker Long

73 papers receiving 4.9k citations

Hit Papers

A Comparison of Continuou... 1996 2026 2006 2016 1996 2002 1996 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
    1996 2.0k citations Robyn J. Barst, Lewis J. Rubin et al. New England Journal of Medicine profile →
  2. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
    2002 611 citations Ronald J. Raymond, Alan L. Hinderliter et al. Journal of the American College of Cardiology profile →
  3. Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome
    1996 414 citations Walker Long et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Walker Long 4.7k 2.2k 889 859 529 74 5.2k
P Duroux 3.0k 0.6× 1.2k 0.6× 182 0.2× 756 0.9× 363 0.7× 87 4.3k
E Weitzenblum 7.3k 1.6× 2.3k 1.1× 1.2k 1.3× 706 0.8× 643 1.2× 153 8.3k
Serge Brimioulle 2.7k 0.6× 2.0k 0.9× 229 0.3× 866 1.0× 108 0.2× 111 4.1k
Ari Chaouat 7.6k 1.6× 3.2k 1.5× 944 1.1× 716 0.8× 1.1k 2.0× 138 8.6k
Jean‐Luc Vachiéry 4.9k 1.1× 3.7k 1.7× 175 0.2× 1.2k 1.4× 601 1.1× 132 6.1k
John P. Kinsella 6.9k 1.5× 859 0.4× 2.3k 2.6× 3.3k 3.8× 96 0.2× 176 8.0k
Paul R. Forfia 4.1k 0.9× 4.1k 1.9× 62 0.1× 851 1.0× 261 0.5× 114 5.9k
Celia M. Oakley 950 0.2× 3.4k 1.6× 77 0.1× 975 1.1× 119 0.2× 89 4.5k
Micha T. Maeder 1.2k 0.3× 3.4k 1.6× 218 0.2× 1.1k 1.3× 90 0.2× 164 4.8k
Stuart J. Hutchison 3.2k 0.7× 2.7k 1.3× 75 0.1× 1.2k 1.5× 77 0.1× 84 4.4k

Countries citing papers authored by Walker Long

Since Specialization
Citations

This map shows the geographic impact of Walker Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walker Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walker Long more than expected).

Fields of papers citing papers by Walker Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walker Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walker Long. The network helps show where Walker Long may publish in the future.

Co-authorship network of co-authors of Walker Long

This figure shows the co-authorship network connecting the top 25 collaborators of Walker Long. A scholar is included among the top collaborators of Walker Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walker Long. Walker Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raymond, Ronald J., Alan L. Hinderliter, Park W. Willis, et al.. (2002). Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. Journal of the American College of Cardiology. 39(7). 1214–1219. 611 indexed citations breakdown →
2.
Hinderliter, Alan L., Park W. Willis, Walker Long, et al.. (1999). Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. The American Journal of Cardiology. 84(4). 481–484. 123 indexed citations
3.
Barst, Robyn J., Lewis J. Rubin, Walker Long, et al.. (1996). A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension. New England Journal of Medicine. 334(5). 296–301. 1970 indexed citations breakdown →
4.
Archer, Stephen L., et al.. (1996). A Placebo-Controlled Trial of Prostacyclin in Acute Respiratory Failure in COPD. CHEST Journal. 109(3). 750–755. 62 indexed citations
5.
Casiro, Oscar, William Bingham, Michael G. Whitfield, et al.. (1995). One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. The Journal of Pediatrics. 126(5). S53–S60. 27 indexed citations
6.
Corbet, Anthony, Walker Long, Robert E. Schumacher, Jeffrey S. Gerdes, & Robert B. Cotton. (1995). Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. The Journal of Pediatrics. 126(5). S5–S12. 23 indexed citations
7.
Gong, Alice, Endla K. Anday, Stephen J. Boros, et al.. (1995). One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. The Journal of Pediatrics. 126(5). S68–S74. 19 indexed citations
8.
9.
Courtney, Sherry E., Walker Long, Douglas McMillan, et al.. (1995). Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. The Journal of Pediatrics. 126(5). S43–S52. 21 indexed citations
10.
Mauskopf, Josephine, Martin E. Backhouse, David E. Jones, et al.. (1995). Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: Impact on hospital resource use and charges. The Journal of Pediatrics. 126(1). 94–101. 24 indexed citations
11.
Walther, Frans J., Martha D. Mullett, Robert E. Schumacher, et al.. (1995). One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: Results of a double-blind trial. The Journal of Pediatrics. 126(5). S13–S19. 21 indexed citations
12.
White, Alice, et al.. (1995). Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement. American Journal of Obstetrics and Gynecology. 173(1). 286–290. 21 indexed citations
13.
14.
Sherman, Michael P., T. Allen Merritt, Walker Long, et al.. (1994). Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. The Journal of Pediatrics. 125(6). 939–947. 30 indexed citations
15.
Stevenson, David K., Frans J. Walther, Walker Long, et al.. (1992). Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The Journal of Pediatrics. 120(2). S3–S12. 72 indexed citations
16.
Bhutani, Vinod K., Soraya Abbasi, Walker Long, & Jeffrey S. Gerdes. (1992). Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. The Journal of Pediatrics. 120(2). S18–S24. 53 indexed citations
17.
Gerdes, Jeffrey S., Jeffrey A. Whitsett, & Walker Long. (1992). Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant. The Journal of Pediatrics. 120(2). S34–S39. 24 indexed citations
18.
Corbet, Anthony, Richard L. Bucciarelli, Steven Goldman, et al.. (1991). Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial. The Journal of Pediatrics. 118(2). 277–284. 163 indexed citations
19.
Long, Walker, Edward E. Lawson, J. R. Perry, Herbert S. Harned, & G. William Henry. (1985). Radionuclide diagnosis of infradiaphragmatic total anomalous pulmonary venous drainage. Pediatric Cardiology. 6(2). 69–75. 3 indexed citations
20.
Long, Walker, Martin H. Ulshen, & Edward E. Lawson. (1984). Clinical Manifestations of Congenital Syphilitic Hepatitis. Journal of Pediatric Gastroenterology and Nutrition. 3(4). 551–555. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Duroux Breakdown of academic impact, for papers by E Weitzenblum Breakdown of academic impact, for papers by Serge Brimioulle Breakdown of academic impact, for papers by Ari Chaouat Breakdown of academic impact, for papers by Jean‐Luc Vachiéry Breakdown of academic impact, for papers by John P. Kinsella Breakdown of academic impact, for papers by Paul R. Forfia Breakdown of academic impact, for papers by Celia M. Oakley Breakdown of academic impact, for papers by Micha T. Maeder Breakdown of academic impact, for papers by Stuart J. Hutchison
Rankless by CCL
2026